Pharma Foods International Co Ltd
TSE:2929

Watchlist Manager
Pharma Foods International Co Ltd Logo
Pharma Foods International Co Ltd
TSE:2929
Watchlist
Price: 938 JPY 1.3%
Market Cap: 26.3B JPY
Have any thoughts about
Pharma Foods International Co Ltd?
Write Note

Pharma Foods International Co Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Pharma Foods International Co Ltd
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Pharma Foods International Co Ltd
TSE:2929
Accounts Payable
ÂĄ1B
CAGR 3-Years
-22%
CAGR 5-Years
27%
CAGR 10-Years
25%
GNI Group Ltd
TSE:2160
Accounts Payable
ÂĄ1.5B
CAGR 3-Years
78%
CAGR 5-Years
47%
CAGR 10-Years
45%
PeptiDream Inc
TSE:4587
Accounts Payable
ÂĄ3.4B
CAGR 3-Years
202%
CAGR 5-Years
127%
CAGR 10-Years
85%
Takara Bio Inc
TSE:4974
Accounts Payable
ÂĄ850m
CAGR 3-Years
-20%
CAGR 5-Years
-3%
CAGR 10-Years
-7%
S
StemRIM Inc
TSE:4599
Accounts Payable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Cuorips Inc
TSE:4894
Accounts Payable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Pharma Foods International Co Ltd
Glance View

Market Cap
26.3B JPY
Industry
Biotechnology

Pharma Foods International Co., Ltd. engages in the development and sale of functional food materials. The company is headquartered in Kyoto, Kyoto-Fu and currently employs 293 full-time employees. The company went IPO on 2006-06-12. The firm operates through three business segments. The Mail Order segment is engaged in the sale of supplement Tamagosamin, cosmetics Pearl Skin Lanchel and Derma QII Mild Peeling Gel, through advertising media such as televisions and radios. The Functional Materials segment is engaged in the development and sale of functional materials such as GABA, Bonepep, Folic Acid eggs and Chicken Egg Antibody. The firm is also engaged in the planning and sale of original equipment manufacturer (OEM) products such as supplements and beverages. The Biomedical segment is engaged in the antibody contract manufacture business for drug discovery and diagnostics, and life science information (LSI) business for analysis and efficacy evaluation test of materials and products.

Intrinsic Value
2 599.9 JPY
Undervaluation 64%
Intrinsic Value
Price

See Also

What is Pharma Foods International Co Ltd's Accounts Payable?
Accounts Payable
1B JPY

Based on the financial report for Oct 31, 2024, Pharma Foods International Co Ltd's Accounts Payable amounts to 1B JPY.

What is Pharma Foods International Co Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
25%

Over the last year, the Accounts Payable growth was -10%. The average annual Accounts Payable growth rates for Pharma Foods International Co Ltd have been -22% over the past three years , 27% over the past five years , and 25% over the past ten years .

Back to Top